Hit enter to search or ESC to close
Immuneering Corporation
  • ABOUT
    • Our Approach
    • Disease Cancelling Technology
    • Team
  • SERVICES
  • PIPELINES
  • NEWSROOM
  • PUBLICATIONS
  • CONTACT
    • Inquiries
    • Locations
    • Join Our Team
  • ABOUT
    • Our Approach
    • Disease Cancelling Technology
    • Team
  • SERVICES
  • PIPELINES
  • NEWSROOM
  • PUBLICATIONS
  • CONTACT
    • Inquiries
    • Locations
    • Join Our Team
Tag

Immuno-Oncology Archives - Immuneering Corporation

immun-ops2020 In News

Immuneering Completes Oversubscribed $62 Million Series B Financing

Financing to support advancement of Immuneering’s lead drug programs targeting cancers driven by alterations in the RAS/MAPK pathway and pipeline development of earlier programs in neuroscience and immuno-oncology.

Read More
Immuneering logo
  • ABOUT
  • SERVICES
  • PIPELINES
  • NEWSROOM
  • PUBLICATIONS
  • CONTACT
  • Terms of Use
  • Privacy Policy

© 2021 Immuneering Corporation.